Astrazeneca Covid 19 Vaccine
Astrazeneca Covid 19 Vaccine News
COVID-19 vaccine: Centre assures 50% more allocation than May, says 12 crore doses will be supplied in June
Of the total, about 6.09 crore doses will be supplied to states and UTs for vaccinating healthcare and frontline workers, and those aged over 45 years
AstraZeneca vaccine: EU regulator confirms unusual blood clots as 'very rare' side effect, but says jab still safe
It said most of the cases reported have occurred in women under 60 within two weeks of vaccination — but based on the currently available evidence, it was not able to identify specific risk factors
WHO refutes safety fears over AstraZeneca's COVID-19 vaccine after several nations suspend rollout
The WHO, which said its vaccines advisory committee was examining the safety data coming in, stressed that no causal link has been established between the vaccine and clotting
Germany approves AstraZeneca COVID-19 vaccine for citizens over 65 years of age
The country had previously cited lack of sufficient data to greenlight the vaccine for older people
Looking back at how Pfizer-BioNTech won the COVID-19 vaccine race
BioNTech held webinars for nurses and doctors who will soon administer the shot, with 1,100 questions answered during the sessions.
India in talks with Moderna over COVID-19 vaccine development after biotech firm says its candidate shows 95% efficacy
'We are also in dialogue with Pfizer, Serum Institute, Bharat Biotech and Zydus Cadila for their vaccine candidate in terms of safety, immunogenicity and efficacy,' a government official said
Roll-out of Feluda test for detecting COVID-19 expected in next few weeks, says Harsh Vardhan
In the fifth episode of 'Sunday Samvaad', the health minister also said the decision on emergency use authorisation for vaccines against the virus will depend on results of the clinical trials
India records 83,809 new cases, COVID-19 tally crosses 49 lakh; 5 states account for 60% of active cases, says health ministry
India's COVID-19 caseload rose to 49,30,236 while the toll climbed to 80,776 with 1,054 people succumbing to the disease in 24 hours, the health ministry's data showed.
India readies five sites for final phase of human trials of Oxford's COVID-19 vaccine
Serum Institute of India has been chosen by Oxford University and its partner AstraZeneca to manufacture the COVID-19 vaccine
Coronavirus Outbreak: AstraZeneca in talks with governments to replicate UK vaccine deal
The UK aims to have 30 million doses of the vaccine ready by September if the human trial phase at Oxford University is successful.